IFN‐γ and TNF‐α secretion by CD4+ and CD8+ TCRαβ+ T‐cell clones derived early after allogeneic bone marrow transplantation
- 1 August 1993
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 51 (2) , 73-79
- https://doi.org/10.1111/j.1600-0609.1993.tb01596.x
Abstract
Secretion of the potentially antileukaemic cytokines IFN‐γ and TNF‐α was investigated for CD4 + and CD8 + TCRαβ+ T‐cell clones derived from 4 leukaemia patients 3–6 weeks after allogeneic BMT. We investigated cytokine secretion in response to the activation signal accessory cells + phytohaemagglutinin + Interleukin 2. All clones derived after BMT were capable of IFN‐γ and TNF‐α secretion, and both for CD4+ (n = 96) and CD8+ (n = 8) T cells quantities of IFN‐γ and TNF‐α were significantly correlated with one another. When comparing the overall results for posttransplant and normal T‐cell clones derived from 2 bone marrow donors (n = 65), both CD4+ and CD8+ TCRαβ+ T‐cell clones showed increased IFN‐γ production, and CD4+ but not CD8+ clones showed a decreased TNF‐α secretion. The results suggest that noncytotoxic T cells derived after allogeneic BMT can produce IFN‐γ and TNF‐α and may thus be capable of mediating antileukaemic effects.Keywords
This publication has 25 references indexed in Scilit:
- IL2‐ and IL4‐dependent proliferation of T‐cell clones derived early after allogeneic bone marrow transplantation: Studies of patients with chronic myelogenous leukaemiaEuropean Journal of Haematology, 1992
- CD4+TCRαβ+ T-cells developing after allogeneic bone marrow transplantation in patients with chronic myelogenous leukaemia. Dipyridamole inhibits functionally heterogeneous T-cell clonesInternational Journal of Immunopharmacology, 1991
- Lymphocyte activation in patients with acute myeloid leukaemia Evidence for the presence of myeloblast antigen?Cancer Immunology, Immunotherapy, 1991
- Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1991
- Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon αCancer Immunology, Immunotherapy, 1991
- Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.Journal of Clinical Investigation, 1989
- Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1989
- γ-IFN induces a differential expression of HLA-DR, DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiationLeukemia Research, 1989
- Differential secretion of tumor necrosis factor-α and granulocyte/macrophage colony-stimulating factors but not interferon-γ from CD4 compared to CD8 human T cell clonesEuropean Journal of Immunology, 1989
- The effects of cyclosporin A on the immune systemImmunology Today, 1981